24th Pharmaceutical & Medical Device Ethics & Compliance Congress Features Annual CCO Fireside Chat; Agenda-at-a-Glance Updated
  • A Hybrid Onsite Conference and Internet Event
  • Sponsored by Pharmaceutical Compliance Forum
  • Media Partners: Policy & Medicine Compliance Update
  • October 25-27, 2023
  • Gaylord National Resort & Convention Center
  • National Harbor, MD
  • www.PharmaCongress.com

Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com

Click here for discounted registration.

Click here for Agenda-at-a-Glance.


Michael R. Clarke, JD, CCEP
Vice President, Global Chief Compliance Officer, ConvaTec, Bridgewater, NJ

Jake DeBoever, JD
Vice President, Chief Compliance Officer, Dermavant Sciences, Dallas, TX

Anisa Dhalla
Global Head, Ethics and Compliance, UCB, Member, UCB's Diversity, Equity and Inclusion core team, Acworth, GA

Melissa Lozner, JD
Senior Vice President, Chief Compliance Officer, Regeneron, Tarrytown, NY

Paul Silver
Principal and Corporate Intelligence Services Practice Leader, Deloitte Advisory, Atlanta, GA (Moderator)

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- JULY 24, 2023: The Pharmaceutical Compliance Forum (PCF) is pleased to announce that the Twenty-Fourth Pharmaceutical & Medical Device Ethics and Compliance Congress will be held at the Gaylord National Resort & Convention Center, National Harbor, MD.

As of Monday, July 27, 2023. This is a draft subject to change. To be updated regularly. All times listed are EDT.
Click below to view the full PDF


Robert K. DeConti, JD
Chief Counsel to the Inspector General, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC

Kristy Grant-Hart, JD, CCEP-I
Founder and CEO, Spark Compliance; Former Chief Compliance Officer, United International Pictures; Director of Compliance, Europe, MEA, Carlson Wagonlit Travel, Los Angeles, CA

Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD

Geoffrey S. Martha
Chairman and Chief Executive Officer, Medtronic, Minneapolis, MN

Lisa Miller, JD
Deputy Assistant Attorney General, Fraud and Appellate Sections, Criminal Division, US Department of Justice, Washington, DC

Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC

Richard Simkin
Chief Commercial Officer, Indivior; Former President North America, Reckitt Benckiser Pharmaceuticals, Richmond, VA


Nanette Almeida, CHC
Compliance Director, Azurity Pharmaceuticals; Former Director of Policies and Monitoring, Kaleo, Richmond, VA

Eliza L. Andonova, JD
Partner, Global Regulatory, Hogan Lovells, Washington, DC

Samantha Barrett Badlam, JD
Partner, Ropes & Gray, LLP, Washington, DC

Yogesh Bahl, MBA
Partner and Leader, Life Sciences and Healthcare Practice, Resolution Economics Lifesciences, New York, NY

Eric M. Baim, JD
Partner, Dovetail Consulting Group LLC; Former VP, Head of Compliance, US, Shire, Boston, MA

Suneal Bedi, JD, PhD
Assistant Professor OF Business Law & Ethic, Kelley School of Business, Indiana University, Bloomington, IN

David Berger, JD
Senior Managing Director and Life Sciences Practice Lead, Ankura, New York, NY

Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Research Triangle Park, NC

Brian A. Bohnenkamp, JD, MHA
Partner, FDA and Life Sciences, King and Spalding, Washington, DC

Eve M. Brunts, JD, LLM
Partner, Ropes & Gray, Boston, MA

Terra Buckley, JD
Vice President, Head of Compliance Advisory Services, MedPro Systems, Summit, NJ

Tim Canonico
Partner, Pharmaceutical and Life Sciences and Managed Services Leader, Managed Services Platform, Chief Technology Officer, PwC, New York, NY

Cindy Cetani, LPEC
Chief Integrity & Compliance Officer, Indivior; Former Group Integrity & Compliance, Head, Compliance Operations, Novartis, Glen Allen, VA

Katherine Chaurette
Senior Vice President, Healthcare Law and Compliance, Blueprint Medicines, Boston, MA

Chris Cobourn, MS
Principal Business Consultant, Chris Cobourn Consulting LLC, Placida, FL

Benjamin Correa, JD
Partner, Sidley Austin LLP, Washington, DC

Clarissa Crain
Managing Director, Deloitte & Touche LLP, Phoenixville, PA

Adriana Davies, JSM
Vice President, Compliance & Data Privacy, US, Office of Ethics & Compliance, Smith & Nephew, Jacksonville, FL

James M. Dawson
Vice President Compliance Solutions, Qordata, Carrboro, NC

Julie DeLong, MA, CFA
Senior Managing Director, Ankura Consulting Group, LLC, Atlanta, GA

Greg Demske, JD
Partner, Goodwin Procter LLP; Former Chief Counsel, HHS Office of Inspector General, Washington, DC

Chris DePhillips, JD
Senior Vice President, Chief Operating Officer and General Counsel, Porzio Life Sciences, New York, NY

Peter Dieners, JD
Regional Managing Partner (Germany) and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Dűsseldorf, Germany

Stefanie A. Doebler, JD
Partner and Co-chair, Health Care Practice Group, Covington & Burling LLP, Washington, DC

Dominique Donovan, MBA
Senior Manager, Life Sciences Advisory, Deloitte & Touche, LLP, Conshohocken, PA

Avia M. Dunn, JD
Partner, Skadden, Arps, Slate, Meagher & Flom LLP, Washington, DC

Gildas Durand
Partner/Principal, Forensic & Integrity Services, EY, Miami, FL

Keith Edelman, JD
Principal Assistant Chief, FCPA Unit, Criminal Division, US Department of Justice, Washington, DC

Jacob T. Elberg, JD
Associate Professor & Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall University School of Law, Newark, NJ

Andrea Falcione, JD, CCEP
Chief Ethics and Compliance Officer and Head of Advisory Services, Rethink Compliance, Boston, MA

J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US
Managing Director, Epsilon Life Sciences LLC, Atlanta, GA

Ronald N. Feldman
President and Creative Director, Learnings & Entertainments, Chicago, IL

Alison Fethke, JD
Counsel, Ropes & Gray, LLP, Former Counsel, Legal Regulatory & Compliance, Abbvie, Chicago, IL

Pat Fogarty, JD
Deputy General Counsel & Senior Vice President of Legal, AdvaMed; Former Compliance Officer & Assistant General Counsel, BIO, Washington, DC

Sarah A. Franklin, JD
Partner and Vice-chair, Life Sciences Investigations Practice, Covington & Burling LLP, Washington, DC

Emily Gainor, MA, JD
Head of Compliance, Senior Director, Corporate and Compliance Counsel, Ironwood Pharmaceuticals, Auburndale, MA

Mark Gardner, MBA, JD
Directing Attorney, Gardner Law; Adjunct Professor of Law, Mitchell Hamline School of Law, Stillwater, MN

Stephanie Garfield, JD
Senior Legal Counsel, Rhythm Pharmaceuticals, Boston, MA

Ihab Ghaly, MBA
Co-founder and Managing Director, G & M Health LLC, Matawan, NJ

Gary F. Giampetruzzi, JD
Partner & Global Chair Life Sciences Department, Paul Hastings; Former VP, Assistant GC, Pfizer, New York, NY

Abraham Gitterman, JD
Senior Associate, Arnold & Porter Kaye Scholer LLP, Newark, NJ

Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, USDOJ, Washington, DC

Noah C. Goldstein, JD
Counsel, Porzio, Bromberg & Newman, PC, Westborough, MA

Kris Hall, JD, CIPP/CIPM
Managing Director, Dovetail Consulting Group, LLC, Bridgton, ME

Margaux J. Hall, JD
Partner, Ropes & Gray, LLP, Washington, DC

Todd Haugh, JD
Associate Professor of Business Law and Ethics, Indiana University, Bloomington, IN

Suneeta Hazra, JD
Partner, Arnold & Porter Kaye Scholer LLP; Former Chief, Criminal Division, US Attorneys' Office, District of Colorado, Denver, CO

Martin J. Healy, JD
Principal, Porzio, Bromberg & Newman, PC, New York, NY

Michael G. Hercz, JD
Senior Vice President and General Counsel, Sentynl, Los Angeles, CA

Emily F. Hodge, JD
Partner, Choate, Hall & Stewart LLP, Boston, MA

Casey Horton
Managing Director, Epsilon Life Sciences; Former Director, Compliance Operations, AbbVie, Chicago, IL

William Hrubes, MS
Chief Risk and Compliance Officer, PharmaEssentia, Columbia, MD

Brenna Jenny, JD
Partner, Sidley Austin LLP; Former Principal Deputy General Counsel & CMS Chief Legal Officer, HHS, Washington, DC

Marci Juneau, MBA
Partner, Helio Health Group, Atlanta, GA

Jonathon L Kellerman
Partner and Director, Boston Consulting Group (BCG); Former EVP & Global CCO, AbbVie and Allergan, New York, NY

Shannon Capone Kirk, JD
Managing Principal and Global Head, Advanced E-Discovery and AI Strategy, Ropes and Gray, Boston, MA

Andrea Kocharyan, JD
Vice President, Senior Counsel, Flagship Pioneering; Former VP, Head of Legal and Compliance, Zealand US, Inc., Cambridge, MA

Daniel Koerner
Senior Director, Potomac River Partners, New York, NY

Jocelyn Lafond, LLB, LLM
Vice President, General Counsel and Corporate Secretary, Theratechnologies, Montreal, Quebec, Canada

Dominique Laymand
Of Counsel, Clifford Chance; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France

Angelique Lee, JD
Vice President, Global Chief Compliance & Ethics Officer, Jazz Pharmaceuticals, Carlsbad, CA

Aaron Leskow, MS
Healthcare Compliance Specialist, Immunocore, Conshohocken, PA

Kirsten Liston
Principal and Founder, Rethink Compliance, Westminster, CO

Brian Long, MBA
Partner, Health Industries Risk & Regulatory, PwC, Chicago, IL

Tim Loper
Executive Director, Head of Compliance and Ethics Investigations and Integrity Line, Bristol Myers Squibb' Former Assistant Deputy Chief, US Department of Justice, Princeton, NJ

Michael K. Loucks, JD
Partner, Skadden, Arps, Slate, Meagher & Flom LLP; Former Acting US Attorney, Massachusetts, US Department of Justice, Boston, MA

Emily Mason, JD
Vice President, Worldwide Compliance and Business Ethics, Amgen, Los Angeles, CA

Jim Massey, MS
Chief Sustainability Officer, Zai Lab; Author, Trust in Action: A Leaders Guide to ACT. Right. Now., Washington DC

Chris Matteson
Senior Manager, EY; Former Senior Director Risk Mitigation and CIA Management, Johnson & Johnson, Marlton, NJ

Kirsten Mayer, JD
Interim Legal Director, ACLU of Massachusetts; Former Head, US Compliance & VP Legal, argenx; Former Partner, Ropes & Gray LLP, Boston, MA

Kevin McAnaney, JD
Law Office of Kevin McAnaney; Former Chief, Industry Guidance Branch, HHS Office of Counsel to the Inspector General, Bethesda, MD

Jennifer McGee, JD
Senior Vice President, Global Chief Ethics and Compliance Officer, Otsuka Pharmaceutical Companies (U.S.), Rockville, MD

Robert Melillo, JD
Co-founder and Managing Director, G&M Health, LLC, Frenchtown, NJ

Todd Mello, MBA
Senior Managing Director, Healthcare Valuation, FTI Consulting, Brentwood, TN

Rore Middleton, JD
Vice President, Compliance and Ethics, Blueprint Medicines; Member, Chief, Boston, MA

Daniel O'Connor
Senior Vice President, NXLevel Compliance, Lambertville, NJ

Danielle Pelot, JD
Partner and Deputy Leader, Government Investigations Group, Choate, Hall & Stewart LLP, Boston, MA

John Poulin
Chief Technology Officer and Partner, Helio Health Group, Boston, MA

John Rademacher
Principal, Forensic Services, Charles River Associates, Chicago, IL

Nikki Reeves, JD
Partner & Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding, Washington, DC

Brian Riewerts
Partner, Pharmaceutical and Life Sciences, Cyber Risk and Regulatory Leader, PwC, Washington, DC

Jeff Rosenbaum, MBA
Partner & Co-Founder, Dovetail Consulting Group; Former SVP, Chief Compliance and Risk Officer, Shire, Boston, MA

Mona Peterson Rosow, JD, MPH
Chief Compliance Officer, Mozarc Medical; Former Compliance Officer, Medtronic, Minneapolis, MN

Jeffrey Scott, JD
Lead Compliance Counsel - Digital, Reporting, and Analytics, Pfizer, Philadelphia, PA

Brian Segobiano
Managing Director and Chief Privacy Officer, Epsilon Economics, Chicago, IL

Patterson (Pat) Shafer
Managing Director, FTI Consulting, Ridgefield, CT

Gregg Shapiro, JD
Founder, Gregg Shapiro Law, LLC; Former Assistant US Attorney and Chief, Affirmative Civil Enforcement Unit, US Attorney's Office, District of Massachusetts, Boston, MA

Michael L. Shaw, JD
Principal, Global Head of Risk & Compliance, ZS; Former Vice President and Compliance Officer, Global Therapy Areas and US Pharma, GlaxoSmithKline, Princeton, NJ

James Sheehan, JD
Chief, Charities Bureau, NY Attorney General; Former NY Medicaid IG; Former Associate United States Attorney, Eastern District of PA, New York, NY

Sara R. Simon, JD
Counsel, Porzio, Bromberg & Newman, PC, New York, NY

Torsten Syrbe, JD
Partner, Clifford Chance, Dűsseldorf, Germany

Jack Tanselle, MBA
Managing Director, Deloitte Touche LLP, Indianapolis, IN

Ann-Marie Tejcek, MA
Associate Vice President Global Medical Affairs, Strategy & Transformation, Eli Lilly, Indianapolis, IN

Patricia Thomas
Vice President, Forensic Services, Charles River Associates, Chicago, IL

Manny Tzavlakis
Managing Partner, Helio Health Group; Chief Executive Officer, Helio Argos, Morristown, NJ

L. Stephan Vincze, JD, LLM, MBA
President & CEO, TRESTLE Compliance; Former CCO, Warner Chilcot and TAP Pharma, Boston, MA

Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC

Beth P. Weinman, JD
Counsel, Ropes & Gray LLP; Former Associate Chief Counsel, US Food and Drug Administration, Washington, DC

Matthew Wetzel, JD
Partner, Life Sciences, Goodwin Procter; Former Chief Compliance Officer, GRAIL, Washington, DC



  • An Invitation-only Chief Compliance Officer Roundtable
  • Annual Keynote Addresses by DOJ, FDA and OIG
  • Annual Prosecutors and Senior Ethics & Compliance Professionals Roundtables
  • A Faculty of over 100 & over 40 Substantive Sessions
  • An Industry-only Day Focused on Best Practice Exchange
  • Numerous Networking Opportunities
Click here for discounted registration.

Click here for Agenda-at-a-Glance.


Joseph Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics (PCF Chair)

Christie Camelio
Chief Compliance and Risk Officer, EQRx

Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte

Cheryl Lee, MBA
Vice President, Head of Major Markets Compliance & Ethics, Bristol Myers Squibb

Joshua Marks, JD
Global Head of Ethics & Compliance Program and Governance, Takeda Pharmaceuticals

Donna White, CCEP
Vice President, Compliance Officer, Chiesi


Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Inc.

Tara Shewchuk, JD
Chief Ethics & Compliance Officer, Medtronic

Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker




Sponsor of Pharma Congress



The Congress is applying for approval for Compliance Certification Board (CCB)® Continuing Education Units

The Congress is applying for approval for Pennsylvania CLE Credits.

Attendees may download and self-complete a certificate of attendance which will be posted on the Summit virtual video broadcast platform to file with appropriate certifying bodies which accept such. Click here for more information.

The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those who have lost their jobs as a result of the COVID-19 pandemic.


For Congress registration information, visit https://www.pharmacongress.com/registration-splash/, email reginfo@hcconferences.com, or call 800-503-7419.

For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.

For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.

For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.